Nexsen Limited (ASX: NXN)
Sector: Health Care
Market cap: A$32M (as of 2 Nov 2026)
The Company is a nanobiotechnology company, dedicated to the development of proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural and biosecurity applications.
Data as of 2 Nov 2026.
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 15 May 2026 | Asava Ho_DLias 04 LtD | Entry | ?% → 57.700% | Filing ↗ |
| 26 Feb 2026 | NEXSEN LIMITED (ASX:NXN) and its controlled entities | Decrease | 60.700% → 53.700% | Filing ↗ |
| 6 Feb 2026 | NEXSEN LIMITED (ASX:NXN) | Decrease | 63.7% → 60.7% | Filing ↗ |
| 15 Oct 2025 | Regal Partners Funds Management Pty Ltd and its associates | Entry | ?% → 7.020% | Filing ↗ |
| 14 Oct 2025 | MARK MUZZIN | Entry | ?% → 18.480% | Filing ↗ |
Cash and runway
Ask about NXN in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has NXN raised money in the last year, and at what discount?
- What was NXN's latest cash position and runway?
Loading NXN…